Pharma Medica Research Inc.
Toronto, Ontario, M1R 5A3, Canada
NCT Number: NCT01149746
The objective of this study is to evaluate the comparative bioavailability between Tamsulosin Hydrochloride 0.4 mg Capsules (Teva Pharmaceuticals USA) and Flomax® 0.4 mg Capsules (Boehringer Ingelheim Pharmaceuticals, Inc. USA), after a single-dose in healthy subjects under fasting conditions.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Phase 1
Toronto, Ontario, M1R 5A3, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Test 0.4 mg Capsule
Time frame: Blood samples drawn over 60 hour time period
Bioequivalence based on Cmax
Time frame: Blood samples drawn over 60 hour time period
Bioequivalence based on AUC0-t
Time frame: Blood samples drawn over 60 hour time period
Bioequivalence based on AUC0-inf
Teva Pharmaceuticals USA
Industry
A Single-Dose, Comparative Bioavailability Study of Two Formulations of Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details